Alliqua BioMedical, Inc. (ALQA) financial statements (2021 and earlier)

Company profile

Business Address 100 PINE ST., STE. 500
SAN FRANCISCO, CA 94111
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9262617120
Cash and cash equivalents9262617120
Receivables033    
Inventory, net of allowances, customer advances and progress billings0233110
Inventory0233110
Disposal group, including discontinued operation00     
Prepaid expense and other current assets0
Other undisclosed current assets0013100
Total current assets:97123320131
Noncurrent Assets
Property, plant and equipment0222122
Intangible assets, net (including goodwill) 2440558311
Goodwill 21221400
Intangible assets, net (excluding goodwill) 2228344210
Other noncurrent assets000000
Other undisclosed noncurrent assets      0
Total noncurrent assets:025435710513
TOTAL ASSETS:10335490301714
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1686521
Accounts payable1233211
Accrued liabilities0453210
Employee-related liabilities    2  
Debt 1112    
Derivative instruments and hedges, liabilities000101 
Disposal group, including discontinued operation0      
Business combination, contingent consideration, liability  15 
Deferred revenue and credits     0
Other liabilities     0 
Other undisclosed current liabilities    (2)01
Total current liabilities:1172012432
Noncurrent Liabilities
Long-term debt and lease obligation000120  
Long-term debt, excluding current maturities000120  
Liabilities, other than long-term debt  213000
Deferred tax liabilities, net  11000
Business combination, contingent consideration, liability  112 
Other undisclosed noncurrent liabilities   0300
Total noncurrent liabilities:00226300
Total liabilities:1172237732
Stockholders' equity
Stockholders' equity attributable to parent, including:8163252231412
Common stock0000000
Additional paid in capital167166156148935935
Accumulated deficit(158)(150)(124)(96)(70)(45)(23)
Other undisclosed stockholders' equity attributable to parent      (0)
Total stockholders' equity:8163252231412
TOTAL LIABILITIES AND EQUITY:10335490301714

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues2201815521
Revenue, net382500  
Cost of revenue(2)(7)(7)(6)(3)(2)(2)
Financial services costs1(1)    
Gross profit:0131292(0)(1)
Operating expenses(6)(39)(43)(37)(27)(20)(4)
Operating loss:(5)(26)(31)(28)(25)(20)(5)
Nonoperating income (expense)(2)(2)(2)1(0)(2)(0)
Investment income, nonoperating0 0000(0)
Debt instrument, convertible, beneficial conversion feature    11 
Interest and debt expense(2)(0)(0)(2)(0)(0)0
Loss from continuing operations before equity method investments, income taxes:(9)(29)(33)(29)(25)(22)(5)
Other undisclosed income from continuing operations before income taxes20020  
Loss from continuing operations before income taxes:(7)(29)(33)(28)(25)(22)(5)
Income tax expense (benefit) 112(0)(0)(0)
Loss from continuing operations:(7)(28)(32)(26)(25)(22)(5)
Loss from discontinued operations(7)      
Net loss:(14)(28)(32)(26)(25)(22)(5)
Other undisclosed net income attributable to parent524  00
Net loss attributable to parent:(8)(26)(28)(26)(25)(22)(5)
Preferred stock dividends and other adjustments     (0) 
Net loss available to common stockholders, diluted:(8)(26)(28)(26)(25)(22)(5)

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(14)(28)(32)(26)(25)(22)(5)
Comprehensive loss, net of tax, attributable to parent:(14)(28)(32)(26)(25)(22)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: